ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AMS Advanced Medical Solutions Group Plc

196.00
6.00 (3.16%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Advanced Medical Solutions Group Plc LSE:AMS London Ordinary Share GB0004536594 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  6.00 3.16% 196.00 195.00 196.00 197.40 189.20 190.20 780,056 16:35:15
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Plastics,resins,elastomers 124.33M 20.41M 0.0939 20.81 424.43M

Advanced Medical Solutions Grp PLC Notice of Interim Results (7390F)

01/08/2016 7:01am

UK Regulatory


Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Advanced Medical Solutions Charts.

TIDMAMS

RNS Number : 7390F

Advanced Medical Solutions Grp PLC

01 August 2016

 
   1 August 2016 
 

Advanced Medical Solutions Group plc

("AMS", the "Company" or the "Group")

Notice of Interim Results

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a leading developer and manufacturer of advanced products for the global surgical and wound care markets, will announce its interim results for the six months ended 30 June 2016 on Wednesday 14 September 2016.

A briefing for analysts will be held at 09.00am on the day of the results. Please contact Consilium Strategic Communications for further details.

- End -

For further information, please visit our new website www.admedsol.com or contact:

 
 Advanced Medical Solutions Group                   Tel: +44 (0) 
  plc                                                1606 545508 
 Chris Meredith, Chief Executive 
  Officer 
  Mary Tavener, Group Finance Director 
 
 Consilium Strategic Communications                 Tel: +44 (0) 
                                                    20 3709 5700 
 Mary-Jane Elliott / Jonathan            AMS@consilium-comms.com 
  Birt / Matthew Neal / Hendrik 
  Thys 
 
 Investec Bank PLC (NOMAD & Broker)                 Tel: +44 (0) 
                                                    20 7597 5970 
 Gary Clarence / Daniel Adams 
  / Patrick Robb 
 

About Advanced Medical Solutions Group plc - see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands ActivHeal(R) , LiquiBand(R) and RESORBA(R) as well as supplying under white label.

AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 70 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Company has 510 employees. For more information please see www.admedsol.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NOREKLFLQDFXBBV

(END) Dow Jones Newswires

August 01, 2016 02:01 ET (06:01 GMT)

1 Year Advanced Medical Solutions Chart

1 Year Advanced Medical Solutions Chart

1 Month Advanced Medical Solutions Chart

1 Month Advanced Medical Solutions Chart

Your Recent History

Delayed Upgrade Clock